Menu Search
Equities

Biotricity Inc

BTCY:QBB

Biotricity Inc

Actions
  • Price (USD)0.32
  • Today's Change0.02 / 6.67%
  • Shares traded32.95k
  • 1 Year change-85.32%
  • Beta1.3570
Data delayed at least 15 minutes, as of Sep 20 2024 20:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Biotricity Inc grew revenues 25.15% from 9.64m to 12.06m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -18.66m to -14.09m.
Gross margin71.89%
Net profit margin-117.41%
Operating margin-63.25%
Return on assets-248.61%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2024, Biotricity Inc increased its cash reserves by 37.79%, or 215.60k. Cash Flow from Financing totalled 6.74m or 55.89% of revenues. In addition the company used 6.69m for operations while cash used for investing totalled .
Cash flow per share-1.77
Price/Cash flow per share--
Book value per share-1.27
Tangible book value per share-1.27
More ▼

Balance sheet in USDView more

Biotricity Inc uses little or no debt in its capital structure.
Current ratio0.1989
Quick ratio0.106
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.